Company / Current Liabilities
Integra Lifesciences Holdings Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$456.0M
FY2025
5-year range
$307.0M / $922.1M
FY2021-FY2025
Trend
-50.6%
vs FY2024
Sector context
#80 of 160
Health Care
What the data says
At $456M, Integra Lifesciences Holdings's current liabilities ranks #81 of 160 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $124M in FY2016 to $922M in FY2024.
Based on SEC 10-K filings.
$456M in FY2025 with a 5-year CAGR of +2.6%.
Increased from $307M to $456M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
#81 of 160 in Health CareTop 50% of 160This company $456.0M Sector average $4.5B
▼
-89.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, current liabilities decreased 50.6% year-over-year.
- Ranks #80 out of 160 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $456.0M | -50.6% |
| FY2024 | $922.1M | +200.4% |
| FY2023 | $307.0M | -4.3% |
| FY2022 | $320.9M | -5.6% |
| FY2021 | $340.0M | -15.2% |
| FY2020 | $401.0M | +21.0% |
| FY2019 | $331.3M | +26.2% |
| FY2018 | $262.6M | -24.8% |
| FY2017 | $348.9M | +182.3% |
| FY2016 | $123.6M | -11.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026